[an error occurred while processing this directive]
临床研究

血液透析患者血清25-羟维生素D 与α-Klotho 及主动脉弓钙化的关系

  • 张爱华 ,
  • 郭维康 ,
  • 于玲 ,
  • 刘文虎
展开
  • 1首都医科大学附属北京友谊医院肾内科
    2首都医科大学附属北京朝阳医院血液净化中心

收稿日期: 2019-05-08

  修回日期: 2019-06-11

  网络出版日期: 2019-08-15

基金资助

北京市医院管理局临床医学发展专项经费资助(ZYLX201824)

The relationship between serum 25(OH)D level and the changes of serum α-Klotho and aortic arch calcification in hemodialysis patients#br#

  • ZHANG Ai-Hua ,
  • GUO Wei-Kang ,
  • YU Ling ,
  • LIU Wen-Hu
Expand
  • 1Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China 2Blood Purification Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China

Received date: 2019-05-08

  Revised date: 2019-06-11

  Online published: 2019-08-15

摘要

【摘要】目的评价血液透析(hemodialysis,HD)患者血25羟维生素D[25-hydroxyvitamin D,25(OH)D]和α-Klotho 的相关性及二者在血管钙化中的角色。方法选择北京友谊医院血液净化中心中心HD 患者152 例;周中透析日抽取透析前空腹血,采用全自动电化学发光免疫分析仪检测血清25(OH)D 及全段甲状旁腺激素(intact parathormone,iPTH)水平;夹心酶联免疫吸附法测定血清α-Klotho 水平。后前位胸部X 线摄片评估主动脉弓钙化程度。结果患者血清25(OH)D 的平均水平为(19.97±8.30)ng/ml;维生素D 缺乏的罹患率为69.7%(n=106)。血清α-Klotho 的平均浓度为(421.69±185.28)pg/ml。89 例患者(58.6%)存在主动脉弓钙化。维生素D 缺乏组患者女性更多、血清α-Klotho 水平更低(χ2/t 值分别为9.660,- 2.308;P 值分别为0.006,0.022);主动脉弓钙化罹患率趋向于更高,但未达统计学差异(χ2=3.127,P=0.077)。多元逐步回归分析显示血清25(OH)D 与α-Klotho 水平独立相关(P=0.022)。Logistic回归分析显示年龄和血清25(OH)D 是主动脉弓钙化的独立危险因素(95% CI 值分别为1.069~1.163,0.901~0.998;OR 值分别为1.115,0.948;P 值分别为<0.001, 0.041)。结论维生素D缺乏在HD患者中非常多见,是循环α-Klotho及主动脉弓钙化的独立危险因素。

本文引用格式

张爱华 , 郭维康 , 于玲 , 刘文虎 . 血液透析患者血清25-羟维生素D 与α-Klotho 及主动脉弓钙化的关系[J]. 中国血液净化, 2019 , 18(08) : 535 -538 . DOI: 10.3969/j.issn.1671-4091.2019.08.006

Abstract

【Abstract】Objectives To evaluate the relationship between serum 25(OH)D level and the changes of serum soluble α-Klotho and aortic arch calcification in hemodialysis (HD) patients. Methods This was a crosssectional study enrolled in 152 HD patients from the Dialysis Center of Beijing Friendship Hospital. Fasting blood samples were collected prior to hemodialysis at the second hemodialysis session in a week. Serum 25(OH)D and intact parathyroid hormone (iPTH) were assayed by an automatic electrochemiluminescence immunoassay instrument. Serum α-Klotho was determined using a sandwich enzyme-linked immunosorbent assay (ELISA) kit. Posterior-anterior chest X-ray examination was used to assess aortic arch calcification. Results The average serum 25(OH)D level was 19.97±8.30 ng/ml in the HD patients, in which vitamin D deficiency was found in 106 patients (69.7%). The average serum α-Klotho level was 421.69±185.28 pg/ml. Aortic arch calcification was found in 89 patients (58.6%). In patients with vitamin D deficiency, females were more than males (54.7% vs. 28.3%, c2=9.660, P= 0.006); serum α-Klotho levels were lower (399.16±179.62 pg/ml vs. 473.61±189.62 pg/ml, t=-2.308, P=0.022); and the prevalence of aortic arch calcification was higher but without statistical significance (63.2% vs. 47.8%, c2=3.127, P=0.077). Linear stepwise regression analysis showed that serum 25(OH)D level was independently correlated with serum α-Klotho level (P=0.022). Binary logistic regression analysis confirmed that age (OR=1.115, 95% CI=1.069- 1.163, P<0.001) and serum 25
(OH)D (OR=0.948, 95% CI=0.901-0.998, P=0.041) were the independent risk factors for aortic arch calcification. Conclusions Vitamin D deficiency was prevalent in HD patients. Serum 25(OH)D was the independent risk factor for both circulating α- Klotho and aortic arch calcification. Therefore, serum 25(OH)D assay for HD patients is clinically valuable.

参考文献

参考文献
1. Huish SA, Fletcher S, Dunn JA, et al. Prevalence and treatment of hypovitaminosis D in the haemodialysis population of Coventry. J Steroid Biochem Mol Biol. 2016;164:214-217.
2. Lee SY, Kim HY, Gu SW, et al. 25-hydroxyvitamin D levels and vascular calcification in predialysis and dialysis patients with chronic kidney disease. Kidney Blood Press Res. 2012;35(5):349-354.
3. Chang JH, Ro H, Kim S, et al. Study on the relationship between serum 25-hydroxyvitamin D levels and vascular calcification in hemodialysis patients with consideration of seasonal variation in vitamin D. Atherosclerosis. 2012;220(2):563-568.
4. Wang F, Wu S, Ruan Y, et al. Correlation of serum 25-hydroxyvitamin D level with vascular calcification in hemodialysis patients. Int J Clin Exp Med. 2015;8(9):15745-15751.
5. Lindberg K, Amin R, Moe OW, et al. The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol. 2014;25(10):2169-2175.
6. Hu MC, Kuro-o M, Moe OW. Secreted klotho and chronic kidney disease. Adv Exp Med Biol. 2012;728:126-157.
7. Kwon HY, Lee OH, Kim MJ, et al. The association between mortality and abdominal aortic calcification and relation between its progression and serum calcium concentration in chronic hemodialysis patients. Kidney Res Clin Pract. 2014;33(2):95-102.
8. Yu L, Kang L, Ren XZ, et al. Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis. Kidney Blood Press Res 2018;43:1174-1182.
9. Chiou TT, Liao SC, Kao YY, et al. Gelsolin and Progression of Aortic Arch Calcification in Chronic Hemodialysis Patients. Int J Med Sci. 2016;13(2):92-98.
10. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
11. Grzegorzewska AE, Izdebska A, Niepolski L, et al. Self-Reported Physical Activity, Quality of Life, and Psychological Status in Relation to Plasma 25-Hydroxyvitamin D Concentration in Patients Treated with Hemodialysis. Kidney Blood Press Res. 2016;41(6):886-900.
12. Kara AV, Aldemir MN, Soylu YE, et al. Relationship between Serum Vitamin D Levels and Health-Related Quality of Life in Maintenance Hemodialysis Patients. Blood Purif. 2019 Feb 21:1-9.
13. Martín-Nú?ez E, Donate-Correa J, Muros-de-Fuentes M, et al. Implications of Klotho in vascular health and disease. World J Cardiol. 2014;6(12):1262-1269.
14. Matias PJ, Ferreira C, Jorge C, et al. Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009;24(2):611-618.
15. Hewitt NA, O'Connor AA, O'Shaughnessy DV, et al. Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(7):1143-1149.
16. Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr. 2008;18(5):395-399.
17. Fusaro M, Gallieni M, Rebora P, et al. Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients. J Nephrol. 2016;29(3):419-426.
18. Zhang Y, Darssan D, Pascoe EM, et al. Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies. Nephrol Dial Transplant. 2018;33(10):1742-1751.
19. Hou YC, Lu CL, Zheng CM, et al. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification. Nutrients. 2019 Jan 12;11(1).
20. Hum JM, O'Bryan LM, Tatiparthi AK, et al. Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho. J Am Soc Nephrol. 2017;28(4):1162-1174.
21. Buiten MS, de Bie MK, Bouma-de Krijger A, et al. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients. BMC Nephrol. 2014;15:197.
22. Zheng S, Zheng Y, Jin L, et al. Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis. Iran J Public Health. 2018;47(4):510-518.
23. Lu X, Hu MC. Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease. Kidney Dis (Basel). 2017;3(1):15-23.
文章导航

/

[an error occurred while processing this directive]